‘Alternative’ pharmacies new hubs of Goa’s drugs biz

  • Regulatory Arbitrage: Syndicates are increasingly exploiting the “Vijaya” (cannabis) loophole in AYUSH licensing to sell high-potency narcotics under the guise of traditional Ayurvedic medicine.
  • Tech-Led Enforcement: As of 2026, Goa Police have deployed blockchain-based inventory tracking and AI-facial recognition in “narco-hotspots” to differentiate between legitimate health hubs and dark-store pharmacies.
  • Seizure Precedents: Building on landmark 2022 raids like the Rs 2.23 lakh Porvorim seizure, 2026 policy focuses on the total supply chain, targeting e-pharmacy hubs and cold-storage logistics chains.

The salt spray of Anjuna and the neon glow of Calangute have long masked a sophisticated undercurrent of illicit trade, but in 2026, the front line of Goa’s drug war has moved from the shoreline to the storefront. “Alternative” pharmacies, once the quiet purveyors of holistic wellness, are now being identified as the primary distribution hubs for a new generation of cannabis-infused narcotics that bypass traditional law enforcement nets.

The Evolution of the ‘Pharmacy Front’

The shift represents a strategic pivot for regional cartels. Following the 2022 landmark case in Porvorim—where North Goa police seized 7 kg of cannabis-based products valued at Rs 2.23 lakh—investigators discovered that physical pharmacies were no longer just selling over-the-counter medication. Instead, they were functioning as high-end dispensaries for unregulated “Vijaya” formulations.

By 2026, the complexity of these operations has scaled. The state’s Anti-Narcotics Cell (ANC) reports that these establishments often operate under valid AYUSH licenses meant for traditional Ayurvedic treatments. However, the concentration of THC (Tetrahydrocannabinol) in the “medicinal” oils and tinctures sold often exceeds legal thresholds by a factor of ten, creating a gray market that thrives on regulatory ambiguity.

“The issue is no longer just street peddling. We are seeing highly organized ‘alternative’ medical outlets that use professional branding to mask the sale of narcotics to domestic and international tourists.” — Senior Policy Analyst, Goa Crime Branch (2026).

Regulatory Arbitrage and the AYUSH Loophole

The core of this crisis lies in Regulatory Arbitrage. Under current Indian law, cannabis (Vijaya) is permitted in specific Ayurvedic formulations. Exploiting this, syndicates have flooded the market with products that lack standardized clinical trial data. This mirrors global logistical shifts, such as the GLP-1 Boom where logistics giants are pivoting to specialized pharmaceutical storage, except in Goa, the infrastructure is being repurposed for illicit distribution.

Goa Ayurvedic Medical Association President Dr. Dharmendra Prabhudesai has previously warned that the lack of stringent oversight on “medicinal” labels tarnishes the reputation of legitimate practitioners. The state government’s 2020 flirtation with legalizing marijuana cultivation for medical purposes was shelved, yet the infrastructure for such a market has grown organically—and illegally—nonetheless.

Data-Centric Law Enforcement in 2026

To combat this, the Goa Police have moved beyond the raid-and-seize tactics of 2020 (when 891 raids were conducted). The modern strategy focuses on the “Dark-Store” model. These are pharmacies that serve primarily as fulfillment centers for online orders placed via encrypted messaging apps.

Metric 2020 Baseline 2026 Projection
Pharmacy-Linked Raids <5% of total 22% of total seizures
Digital Surveillance Usage Basic Call Tracking Blockchain & AI-Facial Rec
Average Seizure Value Rs 50,000 – 1 Lakh Rs 5 Lakh+ per location

The state has recently integrated its pharmaceutical database with a centralized oversight system, a move that draws parallels to how some UK regions have debated data sovereignty, such as when Manchester opted out of the Palantir NHS platform due to privacy concerns. In Goa, however, the priority is absolute transparency to curb the narcotics flow.

Blockchain and the Future of Narcotics Suppression

In mid-2026, the North Goa Superintendent of Police announced a pilot program requiring all “Alternative Health Centers” to log high-potency Ayurvedic sales on a state-monitored blockchain ledger. This initiative aims to prevent the “doctor-shopping” and pharmacy-hopping behavior that has characterized the cannabis trade in beach villages like Morjim and Anjuna.

Despite these technological hurdles, the allure of narco-tourism remains high. Primary documents from the Narcotic Drugs and Psychotropic Substances (NDPS) Act continue to be the legal bedrock used to prosecute these hubs, though the “Alternative Pharmacy” model presents a unique challenge: the blurring of lines between a wellness sanctuary and a narcotics bazaar.

“The 2026 policy is clear: if a pharmacy cannot provide a verifiable chain of custody for cannabis-derived ingredients, it is no longer a medical establishment; it is a crime scene.”

As the state continues to grapple with its reputation as a “narco-tourism” destination, the transition of the drug trade into legitimate-looking storefronts suggests that the battle for Goa’s soul will be won not on the beaches, but in the regulatory offices where medical licenses are scrutinized.

More From Category

More Stories Today